ICG 001

27752-1 10 mg
EUR 175
Description: CG001 is a small molecule inhibitor that targets Wnt/β-catenin pathway. It inhibits TCF/β-catenin mediated transcription by competing with β-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM. It can be used to specifically evaluate the role of CBP/beta-catenin association on WNT signaling and cell physiology.

Biotez Laboratories manufactures the biotez btafek-001 reagents distributed by Genprice. The Biotez Btafek-001 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact BioTez. Other Biotez products are available in stock. Specificity: Biotez Category: Btafek-001

ICG 001

Evaluation Sample
EUR 97.2
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1].

TOK-001

10 mg
EUR 282
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1].

TOK-001

10 mM (in 1mL DMSO)
EUR 199.2
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1].

TOK-001

50 mg
EUR 714
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1].

ABL-001

each
EUR 183.6

ABL-001

each
EUR 548.4

ICG-001

  • EUR 1011.60
  • EUR 427.20
  • 25 mg
  • 5 mg

Test Assays information

EPI-001

B6041-200 200 mg
EUR 714
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity.

EPI-001

B6041-50 50 mg
EUR 351.6
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity.

ICG-001

E1KS2662 5mg1​ PHYSICAL AND CHEMICAL PROPERTIES
EUR 625.2

ICG-001

HY-14428 100mg
EUR 968.4

RRx-001

HY-16438 100mg
EUR 2208

B-TFIID TATA-Box Binding Protein Associated Factor 1 (BTAF1) Antibody (Biotin)

20-abx337882
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

RP 001 hydrochloride

B7634-10 10 mg
EUR 398.4

RP 001 hydrochloride

B7634-25 25 mg
EUR 787.2

RP 001 hydrochloride

B7634-5 5 mg
EUR 278.4

ICG-001 ( ?-catenin inhibitor)

SIH-387-25MG 25 mg
EUR 692.4
Description: The substance ICG-001 is a ?-catenin inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO and to 50 mM in ethanol.

ICG-001 ( ?-catenin inhibitor)

SIH-387-5MG 5 mg
EUR 250.8
Description: The substance ICG-001 is a ?-catenin inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO and to 50 mM in ethanol.

BTAF1 siRNA

20-abx909348
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

BTAF1 Rabbit pAb

A5811-100ul 100 ul
EUR 369.6

BTAF1 Rabbit pAb

A5811-200ul 200 ul
EUR 550.8

BTAF1 Rabbit pAb

A5811-20ul 20 ul
EUR 219.6

BTAF1 Rabbit pAb

A5811-50ul 50 ul
EUR 267.6

BTAF1 Antibody

43040-100ul 100ul
EUR 302.4